| Ytd | -37.54% | |
| 1y | -43.87% |
| Open | 4.25 | Prev Close | 4.57 | Low | 4.08 | High | 4.54 | Mkt Cap | 29.62M |
| Vol | 95.62K | Avg Vol | 5.45M | EPS | -24.16 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.83 | 200-d Avg | 4.22 | 1yr Est | 0.00 |
RGNT News
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement
Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
Regentis stock surged 506% Monday after withdrawing its planned public offering, before slipping in
US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech s
https://www.sec.gov/Archives/edgar/data/1912966/000121390026068601/ea0294796-6k_regentis.htm
US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks dow
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
Shares of Sterling Infrastructure Inc (NASDAQ: STRL) jumped 22.5% in pre-market trading after report
Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a reg
Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe pla